Together, the data firmly indicated that knockdown of G3BP1 blocked IL-6-induced STAT3 activation, and G3BP1 is a bridge molecule linking IL-6 and STAT3 signaling in RCC cells. The gene discussed is STAT3; the disease is renal cell adenocarcinoma.